and Parkinson’s disease (PD), today announced the appointment Hui Liu as Director of Biostatistics. “Bringing Ms. Liu on board at this critical stage, as our pivotal Phase 3 AD trial advances ...

Liu, Hui, Juwen Wang, and Wencheng Zhang. 2025. "Spousal Education and Memory Decline: Evidence from the English Longitudinal Study of Ageing." The Gerontologist ...

Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company developing transformative therapies for neurodegenerative disorders such ...